L-Theanine

At standalone 200 mg: subtle. Many users describe nothing acute — a mild "settling" 30–60 min after dosing, slightly easier focus on a single task, slightly less internal noise. People who take it expecting a noticeable felt effect at 200 mg often report disappointment. The subjective signal is roughly: "I noticed I wasn't anxious about something I would normally have been anxious about." Not euphoria, not sedation, not stimulation.

At standalone 400–600 mg: more noticeable calm, still not sedating, sometimes a slight body relaxation / muscle un-clenching. Some users report a mild head-pressure or low-grade headache at the high end.

Paired with caffeine: this is where the effect is profound. 100 mg caffeine + 200 mg L-theanine produces a substantially different state than 100 mg caffeine alone — most users describe it as the alertness of caffeine without the jitter, edginess, or jaw-clenching. Mental focus has a smoother quality; thinking feels less rushed. The pairing is genuinely synergistic, not additive. This is the experience that drove L-theanine into mainstream nootropic use — it's basically the only thing that reliably fixes caffeine's edge without dulling it.

For sleep: 200–400 mg 30–60 min before bed, often stacked with magnesium glycinate or tryptophan. Sleep onset feels easier — less rumination, less "brain still going" before the lights go off. Doesn't knock you out the way diphenhydramine does; it just makes the off-switch less reluctant.

Onset: 30–45 minutes oral. Peak: 60–90 minutes. Tail: 2–3 hours. No discernible morning hangover, no rebound anxiety, no withdrawal on stopping.

• Tolerance buildup: minimal. No documented receptor desensitization with chronic use. Subjective effects are generally stable over months of daily dosing. Some users report mild diminishment of the "felt effect" over weeks (likely psychological / habituation rather than pharmacological), but the caffeine-smoothing effect remains intact long-term.
• Recommended cycle: None needed. Daily-safe with no cycling required. This is one of the cleanest "just take it daily" profiles in the nootropic universe.
• Reset protocol: N/A. If you suspect habituation, a 1–2 week break is more than enough to restore baseline.

Synergistic with

• caffeine: The defining synergy. 1:2 caffeine:theanine (e.g. 100 mg + 200 mg) is the V4 default and the most-replicated combination in the literature. Theanine smooths caffeine's sympathetic edge while preserving (or amplifying) its cognitive lift. Effect on attention, accuracy, and reaction time is greater than either alone. The pairing also appears to reduce caffeine-induced headache risk.
• modafinil: Encyclopedia-confirmed "modafinil + caffeine + L-theanine" stack. Theanine smooths modafinil's mild over-aroused edge in some users; helpful especially during the V5 onboarding window.
• l-tryptophan: Sleep stack. Tryptophan feeds the serotonin → melatonin pathway 30–60 min pre-bed; theanine adds GABA/alpha-wave calm. Both at the V5 sleep slot is clean and additive.
• magnesium-glycinate: Both calming, both NMDA-modulating (Mg is the canonical voltage-dependent NMDA blocker; theanine is the partial antagonist). Convergent on excitatory tone reduction without sedation. Common pre-bed pairing.
• taurine: Both GABAergic, both anti-excitotoxic. Layered calm without sedation. The caffeine + taurine + theanine triple is the energy-drink trifecta and has 2025 meta-analysis support for additive cognitive benefit.
• rhodiola: Both reduce stress-related cognitive impairment via different mechanisms (rhodiola = HPA modulation; theanine = glutamate dampening). Already co-located in V4.
• citicoline / cognizin: No mechanistic conflict; cholinergic + glutamatergic axes are largely orthogonal. Already co-located in V4.

Avoid stacking with

• High-dose stimulants where the alerting effect is the goal: If you want raw amphetamine-class stimulation, theanine may blunt the wanted edge. Not a contraindication, but if you're taking modafinil/dexamphetamine specifically for raw arousal lift on a low-energy day, dropping theanine that morning can sharpen the effect. Most users find theanine helpful with modafinil; minority find it dulling.
• Antihypertensives at high theanine doses: Additive BP-lowering; monitor if combining at 600+ mg theanine.
• Nothing absolute: There are no documented hard contraindications with V4 stack components or V5 planned additions.

Neutral / safe co-administration

• All V4 stack components: NAC, citicoline, magnesium glycinate + threonate, DHA, PS, curcumin, rhodiola, glycine, D3+K2, beta-alanine, vitamin C, creatine.
• All V5 planned additions: modafinil, bromantane, Adamax/Semax, ALCAR, apigenin, astaxanthin, l-tryptophan, taurine.
• All Russian peptides (selank, semax, bromantane), racetams, and noopept.

• Antihypertensives: Mild additive BP-lowering. Not a contraindication; monitor at high doses.
• Stimulant medications (amphetamine, methylphenidate, modafinil, armodafinil): No pharmacokinetic interaction. Theanine may smooth the subjective edge — usually wanted, occasionally not.
• Sedatives / benzodiazepines / z-drugs / alcohol: Theoretical additive sedation at high theanine doses. Not a hard contraindication; at 200 mg this is irrelevant.
• CYP enzymes: L-theanine is not a notable CYP inducer or inhibitor at therapeutic doses. No relevant interactions with modafinil (CYP3A4), bupropion (CYP2B6), or contraceptives.
• SSRIs / SNRIs: No documented interaction at usual doses. Mild theoretical serotonergic component (per 2025 monoamine imaging study) — irrelevant at 200 mg.
• Contraceptives: No interaction.

Minimal direct PGx data — and that's largely because the compound is so clean.

• LAT1 (SLC7A5) transporter polymorphisms: L-theanine crosses the BBB via LAT1, the same transporter used by tryptophan, tyrosine, and other large neutral amino acids. LAT1 variants could theoretically alter brain concentrations, but no clinical PGx data on theanine specifically. Practical implication near zero.
• GAD1/GAD2 (glutamate decarboxylase) variants: GAD makes GABA from glutamate. Variants altering GAD activity could in theory modulate the GABA-bumping component of theanine's effect. No clinical PGx data.
• NMDA receptor subunit variants (GRIN1, GRIN2A, GRIN2B): Could theoretically modulate the partial coagonist/antagonist response. No clinical data.
• COMT / DAT / ANKK1: No documented interaction with theanine response, despite plausible relevance to caffeine-pairing dopaminergic outcomes.
• 23andMe relevance for Dylan: Effectively none. Theanine is so well-tolerated that PGx stratification has not been needed clinically. File for context but don't expect actionable findings.

Bottom line: the compound is broad-spectrum and dose-tolerant enough that genetic stratification doesn't meaningfully change dosing recommendations.

Recommended for Dylan: Stay with V4 Swanson Suntheanine 200 mg. Already in cart, already in routine, costs ~$10–15/mo, no reason to change. If V4 is reorder-time and Swanson Suntheanine is out-of-stock, NOW AlphaWave or Doctor's Best Suntheanine are equivalent substitutes. Generic NOW L-theanine is fine if budget tightens, but the cost differential is too small to justify switching given the V4 already locks Suntheanine.

Cost ceiling: $10–25/month at any reasonable dose level. Theanine is one of the cheapest nootropic adds.

• Baseline (before starting): Subjective stress/anxiety scale (PSS-10 or similar), sleep onset latency self-report, resting heart rate, HRV (Colmi/Oura/Whoop), BP. For Dylan: already in V4, so "baseline" is moot — track ongoing instead.
• During use:
  • HRV trend (weekly average) — should drift up modestly if theanine is doing its parasympathetic-bumping thing.
  • Sleep onset latency (subjective + ring-derived) — should be stable or modestly improved.
  • Resting heart rate — stable or modestly down.
  • Subjective anxiety / stress — stable or down. If self-reported "calmer than expected" in stress contexts, that's the signal.
  • BP (monthly) — stable; flag if trending too low at high doses.
• Post-cycle: N/A — not cycled. If stopping, watch for re-emergence of caffeine jitters or sleep onset difficulty over 1–2 weeks; these are the signals theanine was actively contributing.
• Lab-based (rare/optional): Plasma theanine assay exists but is research-grade only. Salivary cortisol responsiveness to acute stressor (used in 2021 AlphaWave RCT) is the closest objective endpoint; not a standard consumer test.